The STavanger osteoARThritis Study (START)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02876120|
Recruitment Status : Completed
First Posted : August 23, 2016
Last Update Posted : February 1, 2018
|Condition or disease||Intervention/treatment||Phase|
|Knee Osteoarthritis Hip Osteoarthritis||Other: Implementation||Not Applicable|
Previous research has shown that the osteoarthritis care for persons with hip or knee osteoarthritis in Norway has a potential for improvement as the provided care may not necessarily reflect evidence-based guideline recommendations. The purpose of the STavanger osteoARThritis (START) study is to improve the quality of OA care and increase the collaboration between health care professionals in primary health care and across health care levels.
Based on international treatment recommendations for OA care and previous research, a tailored implementation strategy targeting high quality, integrated care for people with OA in Stavanger Municipality will be developed, implemented and evaluated. The care will mainly be provided in the Stavanger primary health care services by physiotherapists (PT) (in private practice) and general practitioners (GP), but will also include collaboration with orthopaedic surgeons in specialist health care at Stavanger University Hospital.
The main aim of the present study is to develop, implement and evaluate effects of a tailored implementation strategy for the START study in Stavanger Municipality.
To evaluate the effects of the START implementation strategy, an interrupted time series design method will be applied. The study period will be divided into three phases: pre-implementation, implementation/transition and post-implementation. Data will be collected at 16 time points; 8 before and 8 after the implementation/ transition phase.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||330 participants|
|Intervention Model:||Single Group Assignment|
|Official Title:||The STavanger osteoARThritis Study in Primary Health Care|
|Study Start Date :||September 2016|
|Actual Primary Completion Date :||November 2017|
|Actual Study Completion Date :||November 2017|
Pre- and post-implementation phases
Pre-implementation phase: during the pre-implementation period persons with hip or knee osteoarthritis will receive "usual care" as it is currently delivered by physiotherapists and general practitioners.
Post-implementation phase: during the post-implementation phase the GPs and PTs will treat persons with hip or knee osteoarthritis according to the START treatment model including providing information/patient education program, supervised exercise and advice/support to loose weight and other non-surgical evidence based treatments modalities prior to being referred to an orthopaedic surgeon
Multifaceted implementation strategy to implement evidence based international osteoarthritis treatment recommendations among GPs and PTs in private practice, template for PT discharge reports to GP, patient osteoarthritis education programs, and facilitate multidisciplinary collaboration between the PTs and GPs.
- Change in patient-reported quality of osteoarthritis care [ Time Frame: 8 weeks pre-implementation vs. 8 weeks post-implementation ]Using the "OsteoArthritis Quality Indicator questionnaire"
- Change in the number of PT discharge summaries to the referring GP [ Time Frame: 8 weeks pre-implementation vs. 8 weeks post-implementation ]
- Change in the proportion of people with OA referred to orthopaedic surgeon in secondary care that has explored non-surgical treatment modalities beforehand [ Time Frame: 8 weeks pre-implementation vs. 8 weeks post-implementation ]
- Change in the proportion of people with OA referred to orthopaedic surgeon in secondary care that has taken an MRI and/or conventional radiographs for OA assessment [ Time Frame: 8 weeks pre-implementation vs. 8 weeks post-implementation ]
- Change in the proportion of people with OA referred to orthopaedic surgeon in secondary care that leads to scheduled joint surgery [ Time Frame: 8 weeks pre-implementation vs. 8 weeks post-implementation ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02876120
|Principal Investigator:||Nina Østerås||Diakonhjemmet Hospital|